risankizumab,tofacitinib,vedolizumab,azacitidine,ustekinumab,ozanimod,upadacitinib,adalimumab,golimumab,infliximab
abbvie,bms,janssen,takeda,pfizer
['psoriasis', 'crohn', 'tofa', 'multiple sclerosis', 'ibd', ' psa', ' uc ']
 we have to get it right in induction! start advanced therapy early in high risk patients. in crohn s disease 80% have high risk features. #aibd2022 
IBD doctor @OHSU | Life and Health Coach | Tweets are my own and are not medical advice